Manu Ohri - Jan 27, 2023 Form 4 Insider Report for GT Biopharma, Inc. (GTBP)

Role
Chief Financial Officer
Signature
/s/ Manu Ohri
Stock symbol
GTBP
Transactions as of
Jan 27, 2023
Transactions value $
$0
Form type
4
Date filed
2/1/2023, 05:02 AM
Previous filing
Jul 19, 2022
Next filing
Apr 10, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GTBP Option to purchase Common Stock Award $0 +500K $0.00 500K Jan 27, 2023 Common Stock 500K $0.84 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/12th of the shares vest on the monthly anniversary of January 1, 2023 until fully vested, subject to full acceleration in the event the reporting person is involuntarily terminated by the registrant.